Array News - ARRY

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
SMALL CAP PRO
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Array Biopharma Inc. (MM) ARRY NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 17.45 - - - 17.45 04:00:01
more quote information »

Recent News

Date Time Source Heading
1/17/201917:00EDGARStatement of Changes in Beneficial Ownership (4)
1/14/201917:03PRNUSArray BioPharma Announces 15.3 Months Median Overall..
1/02/201916:34EDGARStatement of Changes in Beneficial Ownership (4)
12/20/201816:05PRNUSArray BioPharma to Present at the 37th Annual J.P. Morgan..
12/10/201811:24EDGARConfidential Treatment Order (ct Order)
12/06/201816:04EDGARStatement of Changes in Beneficial Ownership (4)
11/20/201816:05PRNUSArray BioPharma to Present at the 30th Annual Piper Jaffray..
11/06/201816:05PRNUSArray BioPharma to Present at the Stifel 2018 Healthcare..
11/05/201816:41EDGARStatement of Changes in Beneficial Ownership (4)
10/30/201808:11EDGARQuarterly Report (10-q)
10/30/201808:04EDGARCurrent Report Filing (8-k)
10/30/201808:00PRNUSArray BioPharma Reports Financial Results for the First..
10/29/201818:13EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201818:13EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201818:12EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201818:11EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201818:11EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201818:11EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201818:11EDGARStatement of Changes in Beneficial Ownership (4)
10/26/201816:46EDGARCurrent Report Filing (8-k)
10/23/201816:05PRNUSArray BioPharma to Report Financial Results for the First..
9/25/201816:05PRNUSArray BioPharma to Present at the 2018 Cantor Global..
9/21/201816:22EDGARStatement of Changes in Beneficial Ownership (4)
9/20/201815:33EDGARCurrent Report Filing (8-k)
9/20/201814:02PRNUSEuropean Commission Approves BRAFTOVI® (encorafenib) in..
9/14/201816:22EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/14/201816:16EDGARProxy Statement (definitive) (def 14a)
9/13/201808:00PRNUSArray BioPharma Announces Publication of BRAFTOVI®..
9/05/201816:20EDGARStatement of Changes in Beneficial Ownership (4)
8/30/201816:05PRNUSArray BioPharma to Present at the Wells Fargo Securities..
8/27/201816:31EDGARProxy Statement - Notice of Shareholders Meeting..
8/17/201817:26EDGARAmended Statement of Beneficial Ownership (3/a)
8/17/201817:23EDGARStatement of Changes in Beneficial Ownership (4)
8/17/201817:23EDGARInitial Statement of Beneficial Ownership (3)
8/17/201817:20EDGARStatement of Changes in Beneficial Ownership (4)
8/17/201816:48EDGARStatement of Changes in Beneficial Ownership (4)
8/17/201816:47EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
8/17/201816:47EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201808:18EDGARCurrent Report Filing (8-k)
8/14/201808:05EDGARAnnual Report (10-k)
8/14/201808:00PRNUSArray BioPharma Reports Financial Results for the Fourth..
8/10/201808:33EDGARCurrent Report Filing (8-k)
8/10/201808:00PRNUSArray BioPharma Names Carrie S. Cox Chairman of its Board of..
8/07/201816:05PRNUSArray BioPharma to Report Financial Results for the Fourth..
8/07/201808:16EDGARCurrent Report Filing (8-k)
8/07/201808:00PRNUSArray BioPharma Receives FDA Breakthrough Therapy..
8/03/201810:41DJNMerck, AstraZeneca Get EMA Orphan Designation for..
7/31/201817:16EDGARStatement of Changes in Beneficial Ownership (4)
7/27/201808:46EDGARCurrent Report Filing (8-k)
7/27/201808:30PRNUSBRAFTOVI™ (encorafenib) + MEKTOVI® (binimetinib) Receives..
See more news about this stock »
Your Recent History
NASDAQ
ARRY
Array
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190118 10:26:15